Erythropoietin and fibronectin compositions for therapeutic and cosmetic applications

Abstract

A method of promoting wound healing or connective tissue reconstruction and a method of treating ischemia in a subject in need thereof in a subject in need thereof are disclosed. The methods comprising topically administering to the subject about 10-30 μg per cm 2 wound tissue of Erythropoietin and about 100-300 μg per cm 2 wound tissue of Fibronectin, thereby promoting wound healing or connective tissue reconstruction or treating ischemia in the subject. Unit dosage forms, pharmaceutical compositions, cosmetic compositions and formulations comprising Erythropoietin and/or Fibronectin are also disclosed.

What is claimed is: 
     
         1 . A method of promoting wound healing or connective tissue reconstruction in a subject in need thereof, the method comprising topically administering to the subject about 10-30 μg per cm 2  tissue of Erythropoietin and about 100-300 μg per cm 2  tissue of Fibronectin, thereby promoting wound healing or connective tissue reconstruction in the subject.